Black Diamond Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
November 08, 2022 at 05:42 pm IST
Black Diamond Therapeutics, Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported net loss was USD 21.65 million compared to USD 35.08 million a year ago. Basic loss per share from continuing operations was USD 0.6 compared to USD 0.97 a year ago.
For the nine months, net loss was USD 70.09 million compared to USD 99.73 million a year ago. Basic loss per share from continuing operations was USD 1.93 compared to USD 2.76 a year ago.